Cynata Therapeutics Limited - PE Ratio

The PE Ratio as of July 2026 (TTM) for Cynata Therapeutics Limited (CYP.AX) is -0.38

According to Cynata Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.38. This represents a change of -89.61% compared to the average of -3.66 of the last 4 quarters.

Cynata Therapeutics Limited (CYP.AX) Historical PE Ratio (quarterly & annually)

How has CYP.AX PE Ratio performed in the past?

The mean historical PE Ratio of Cynata Therapeutics Limited over the last ten years is -10.27. The current -0.38 PE Ratio has changed 269.99% with respect to the historical average. Over the past ten years (40 quarters), CYP.AX's PE Ratio was at its highest in in the June 2007 quarter at 0. The PE Ratio was at its lowest in in the December 2021 quarter at -17.25.

Cynata Therapeutics Limited (CYP.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cynata Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cynata Therapeutics Limited (CYP.AX) Average PE Ratio

How has CYP.AX PE Ratio performed in the past?

The current PE Ratio of Cynata Therapeutics Limited (CYP.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cynata Therapeutics Limited (CYP.AX) PE Ratio vs. Peers

How is CYP.AX’s PE Ratio compared to its peers?

Cynata Therapeutics Limited’s PE Ratio is greater than Radiopharm Theranostics Limited (-1.31), greater than Proteomics International Laboratories Ltd. (-2.60), greater than Prescient Therapeutics Limited (-7.23), greater than Amplia Therapeutics Limited (-8.08), greater than AnteoTech Limited (-80.00), greater than NeuroScientific Biopharmaceuticals Limited (-4.01), greater than Argenica Therapeutics Ltd (-2.10), greater than Genetic Signatures Limited (-1.37), less than Cryosite Limited (29.08), greater than Noxopharm Limited (-4.36),

Build a custom stock screener for Cynata Therapeutics Limited (CYP.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cynata Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cynata Therapeutics Limited (CYP.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cynata Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.